Osada S - Search Results

1

Growth effect of neutrophil elastase on breast cancer: favorable action of sivelestat and application to anti-HER2 therapy.

Nawa M, Osada S, Morimitsu K, Nonaka K, Futamura M, Kawaguchi Y, Yoshida K. Nawa M, et al. Among authors: osada s. Anticancer Res. 2012 Jan;32(1):13-9. Anticancer Res. 2012. PMID: 22213283

2

Application of biological study for met expression to cancer therapy.

Osada S, Yoshida K. Osada S, et al. Anticancer Agents Med Chem. 2010 Jan;10(1):58-63. doi: 10.2174/1871520611009010058. Anticancer Agents Med Chem. 2010. PMID: 20015003 Review.

3

A novel strategy by cryoablation for advanced hepatoma.

Osada S, Yoshida K, Saji S. Osada S, et al. Anticancer Res. 2009 Dec;29(12):5203-9. Anticancer Res. 2009. PMID: 20044637 Free article. Review.

4

Combination therapy of 5-fluorouracil with rapamycin for hormone receptor-negative human breast cancer.

Hosono Y, Osada S, Nawa M, Takahashi T, Yamaguchi K, Kawaguchi Y, Yoshida K. Hosono Y, et al. Among authors: osada s. Anticancer Res. 2010 Jul;30(7):2625-30. Anticancer Res. 2010. PMID: 20682991

5

Aberrant methylation of heparan sulfate glucosamine 3-O-sulfotransferase 2 genes as a biomarker in colorectal cancer.

Tokuyama Y, Takahashi T, Okumura N, Nonaka K, Kawaguchi Y, Yamaguchi K, Osada S, Gazdar A, Yoshida K. Tokuyama Y, et al. Among authors: osada s. Anticancer Res. 2010 Dec;30(12):4811-8. Anticancer Res. 2010. Retraction in: Anticancer Res. 2012 Nov;32(11):5138. PMID: 21187457 Retracted.

6

The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer.

Yawata K, Osada S, Tanahashi T, Matsui S, Sasaki Y, Tanaka Y, Okumura N, Matsuhashi N, Takahashi T, Yamaguchi K, Yoshida K. Yawata K, et al. Among authors: osada s. Anticancer Res. 2016 Oct;36(10):5215-5226. doi: 10.21873/anticanres.11092. Anticancer Res. 2016. PMID: 27798882

7

The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel.

Sakashita F, Osada S, Takemura M, Imai H, Tomita H, Nonaka K, Takahashi T, Seishima M. Sakashita F, et al. Among authors: osada s. Cancer Chemother Pharmacol. 2008 Aug;62(3):379-85. doi: 10.1007/s00280-007-0614-5. Epub 2007 Oct 25. Cancer Chemother Pharmacol. 2008. PMID: 17960385

8

Challenge for a better combination with basic evidence.

Yoshida K, Yamaguchi K, Osada S, Kawaguchi Y, Takahashi T, Sakashita F, Tanaka Y. Yoshida K, et al. Among authors: osada s. Int J Clin Oncol. 2008 Jun;13(3):212-9. doi: 10.1007/s10147-008-0793-z. Epub 2008 Jun 14. Int J Clin Oncol. 2008. PMID: 18553230 Review.

9

A novel strategy for advanced pancreatic cancer - progression of molecular targeting therapy.

Osada S, Yoshida K. Osada S, et al. Anticancer Agents Med Chem. 2009 Oct;9(8):877-81. doi: 10.2174/187152009789124691. Anticancer Agents Med Chem. 2009. PMID: 19538163 Review.

10

Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer.

Osada S, Matsui S, Komori S, Yamada J, Sanada Y, Ihawa A, Tanaka Y, Tokuyama Y, Okumura N, Nonaka K, Hosono Y, Takahashi T, Yamaguchi K, Yoshida K. Osada S, et al. Hepatogastroenterology. 2010 Jan-Feb;57(97):76-80. Hepatogastroenterology. 2010. PMID: 20422876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

396 results

Search Page

Filters